e-learning
resources
Breathe
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Optimising inhaled mannitol for cystic fibrosis in an adult population
Flume Patrick A., Aitken Moira L., Bilton Diana, Agent Penny, Charlton Brett, Forster Emma, Fox Howard G., Hebestreit Helge, Kolbe John, Zuckerman Jonathan B, Button Brenda M.
Source:
Breathe 2015; 11:39-48
Journal Issue:
March
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Flume Patrick A., Aitken Moira L., Bilton Diana, Agent Penny, Charlton Brett, Forster Emma, Fox Howard G., Hebestreit Helge, Kolbe John, Zuckerman Jonathan B, Button Brenda M.. Optimising inhaled mannitol for cystic fibrosis in an adult population. Breathe 2015; 11:39-48
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Inhaled mannitol as treatment for children with cystic fibrosis
Source: Annual Congress 2008 - The use of inhaled mannitol for assessing airway disease
Year: 2008
Safety, tolerability and efficacy of intravenous aminophylline in adult patients with pulmonary exacerbations of cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis
Source: Eur Respir J , 49 (3) 1600987; DOI: 10.1183/13993003.00987-2016
Year: 2017
Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis
Source: Eur Respir J 2011; 37: 1091-1095
Year: 2011
Inhalation therapy in cystic fibrosis
Source: School Course 2013 - Cystic Fibrosis
Year: 2013
Ataluren in nonsense mutation cystic fibrosis patients not receiving chronic inhaled tobramycin: Evaluation of exacerbations and lung function
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Efficacy of alendronate/colecalciferol/calcium in adults with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010
Benefit of aerosol therapy with pulmozyme for children with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 622s
Year: 2005
Home intravenous antibiotic treatments in cystic fibrosis adult patients
Source: Eur Respir J 2002; 20: Suppl. 38, 158s
Year: 2002
Inhaled mannitol in cystic fibrosis: clinical experience in Verona CF centre
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020
A pilot study of inhaled dry-powder mannitol during cystic fibrosis-related pulmonary exacerbation
Source: Eur Respir J 2015; 45: 541-544
Year: 2015
Prescription of Inhaled corticosteroid in non-cystic fibrosis bronchiectasis:a solution or a problem
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Long-term tiotropium bromide therapy was retrospectively analyzed in adults with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
Inhaled steroids in children with non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 392s
Year: 2004
Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis
Source: Eur Respir J 2002; 20: 122-126
Year: 2002
RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis
Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Year: 2006
Inhaled colistin following lung transplantation in colonised cystic fibrosis patients
Source: Eur Respir J 2013; 42: 542-544
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept